ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory

Clinical trial NCT02991274 · COMPLETED

Trial details

NCT number: NCT02991274
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced or Metastatic EGFR(+) NSCLC Patients

Start date: 2017-01-16
Primary completion: 2018-06-29
Enrollment: 897

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.